(Q70482968)
Statements
Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose (English)
Drobyski WR
Keever CA
Roth MS
Koethe S
Hanson G
McFadden P
Gottschall JL
Ash RC
van Tuinen P